Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin dose-ranging study in children with neuropathic bladder
2006-003048-52Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tamsulosin in neurogenic bladder (4 arms), sponsored by Boehringer Ingelheim. Started May 2007; status: completed.
02
Drugs
tamsulosin
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on 2006-003048-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003048-52.